LAMP2 and neoplasm: LAMP2 was evaluated ex vivo via immunofluorescence and was found to be significantly increased in 4T1 tumors than in 67NR ones (Fig. 2H, I), which can be related to the CEST results for tumor pHe and may be associated with increased tumor aggressiveness.